Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
The Tuberous Sclerosis Alliance announced newly updated consensus guidelines for the diagnosis, surveillance, and management of tuberous sclerosis complex (TSC).
RELATED: Oncology Resource Centers
TSC is a genetic disease that causes tumor formation in vital organs, primarily the brain, heart, kidneys, skin, eyes, liver, and lungs. TSC is also the leading cause of epilepsy and autism.
Some of the major recommendations for newly diagnosed individuals of any age include:
- Review the newly diagnosed individual’s nearest three generations
- Undergo MRI of the brain to look for possible subependymal giant cell astrocytomas, subependymal nodules, and others
- Undergo dermatological and dental examinations to check for abnormalities of the skin and teeth frequently associated with TSC
- Obtain a routine ECG to check for abnormal heart rhythm
RELATED: Neurologic Disorders Resource Center
Two peer-reviewed consensus papers detailing the new guidelines have been published in the October issue of Pediatric Neurology.
One is titled “Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference” and the other, “Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.”
For more information call (800) 225-6872 or visit TSAlliance.org.
